Rivastigmine Exelon

Rivastigmine (Exelon) received FDA approval to treat Alzheimer's disease in May 2000, and it is a cholinesterase inhibitor that is very similar to donepezil (Aricept) in its clinical effects. Rivastigmine is given in doses of 3 to 12 mg daily but has to be taken twice (morning and evening), unlike the once-a-day dose for donepezil. Rivastigmine's common side effects include stomach upset, headache, and fatigue. More research is needed to find out if Exelon possesses any significant advantages over Aricept, but current information suggests few differences.

Unraveling Alzheimers Disease

Unraveling Alzheimers Disease

I leave absolutely nothing out! Everything that I learned about Alzheimer’s I share with you. This is the most comprehensive report on Alzheimer’s you will ever read. No stone is left unturned in this comprehensive report.

Get My Free Ebook

Post a comment